Agenus logo

Agenus

291 employees · est. 1994 · Lexington, United States

VS
Immunomic Therapeutics, Inc. logo

Immunomic Therapeutics, Inc.

A privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms

26 employees · est. 2005 · Rockville, United States

Agenus is the older company (1994 vs 2005); Agenus is the larger of the two.

Side-by-Side Comparison

Agenus Immunomic Therapeutics, Inc.
Founded
1994 older 2005
Headquarters
Lexington, United States Rockville, United States
Employees
291 larger 26
Industry
Biotechnology, Health and Wellness, Medical Devices Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Post Ipo Debt Series Unknown
Total Funding
$346.14M $78.40M
Funding Rounds
8 9
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors, Immunotherapy, Cell Therapy, Antibodies, GMP Manufacturing Immunotherapy, Nucleic Acid, Clinical Stage, UNITE Platform, Cancer, Allergy, Infectious Diseases, Lysosomal Associated Membrane Protein, Vaccines, DNA Vaccines, LAMP Technology, Oncology, Animal Health
Website
agenusbio.com immunomix.com
Agenus logo

About Agenus

Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company, founded in 1994 and headquartered in Lexington, MA, aims to expand patient populations benefiting from cancer immunotherapy through combination app...

Immunomic Therapeutics, Inc. logo

About Immunomic Therapeutics, Inc.

Immunomic Therapeutics is a privately-held clinical stage biotechnology company headquartered in the United States. Since its foundation in 2005, the company has been pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigati...

We will tell you when either one moves

BounceWatch watches Agenus and Immunomic Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Agenus and Immunomic Therapeutics... — by email.

Frequently Asked Questions

Agenus. Immunomic Therapeutics, Inc. — A privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Agenus has raised $346.14M while Immunomic Therapeutics, Inc. has raised $78.40M.
Agenus and Immunomic Therapeutics, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Agenus with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Agenus on 12 Sep 2024, and Immunomic Therapeutics, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy